(NTRA) - Analyzing Natera's Short Interest
Express News | Natera: To Redeem $287.5 Mln Convertible Senior Notes Due 2027
Here's How Much You Would Have Made Owning Natera Stock In The Last 5 Years
Express News | Natera Inc : Leerink Partners Raises Target Price to $135 From $130
Insider Sale: CEO and President Steven Chapman Sells Shares of Natera Inc (NTRA)
Natera, Inc.'s (NASDAQ:NTRA) Business Is Yet to Catch Up With Its Share Price
These Are the Stocks With the Highest Increase in Short Interest Within Life Sciences and Diagnostics - Baird
Optimistic Outlook for Natera's Growth Potential Based on ALTAIR Trial and MRD Market Opportunity
$1000 Invested In This Stock 5 Years Ago Would Be Worth $4,300 Today
Jefferies Maintains Natera(NTRA.US) With Buy Rating, Maintains Target Price $142
Analysts Offer Insights on Healthcare Companies: Viking Therapeutics (VKTX), Natera (NTRA) and Argenx Se (ARGX)
Natera to Present at the 28th International Conference on Prenatal Diagnosis and Therapy
Insider Sale: CEO and President Steven Chapman Sells 37,500 Shares of Natera Inc (NTRA)
Natera(NTRA.US) Officer Sells US$4.05 Million in Common Stock
Natera(NTRA.US) Director Sells US$293.94K in Common Stock
Form 144 | Natera(NTRA.US) Officer Proposes to Sell 4.05 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Jul 1, $Natera(NTRA.US)$ Officer STEVEN L CHAPMAN intends to sell 37,500 shares of its common stock on Jul 1, with a total market value of approximately $4.05 million. STEVEN
Morgan Stanley Maintains Natera(NTRA.US) With Buy Rating, Maintains Target Price $125
Positive Outlook for Natera Inc.: Savant Recommends Buy on Strong Study Design and Market Strategy
Cathie Wood's Top and Bottom Performing ARKK Holdings of H1
Natera's New Cancer Trial to Use Signatera for Personalized Treatment